Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Considerations on bringing warehoused HCV patients into active care following interferon-free, direct-acting antiviral drug approval.

Postgraduate medicine - 1 May 2017

Palak Aleksandra, Livoti Christine, Audibert Céline

Abstract excerpt

OBJECTIVES: Until recently, lack of efficacious and tolerable hepatitis C virus (HCV) treatments prompted patient warehousing until better treatment options became available. We investigated whether the introduction of ledipasvir/sofosbuvir precipitated patient return to clinics, thereby changing HCV clinic dynamics. METHODS: Online questionnaire responses indicated the volume of HCV patients followed, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Benzimidazoles
Share to Fluorenes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Practice Patterns, Physicians'

Share to Sofosbuvir

Share to Surveys and Questionnaires

Share to Uridine Monophosphate

Source

Identifiers

PMID: 28277812
DOI: 10.1080/00325481.2017.1304795

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Considerations on bringing warehoused HCV patients into active care following interferon-free, direct-acting antiviral drug approval.PMID 28277812Read ↗

Cascade of Care for Hepatitis C Virus Infection Within the US Veterans Health Administration.Semantic proximity Read ↗

The Lifecycle of Electronic Health Record Data in HIV-Related Big Data Studies: A Qualitative Study of Instances of and Potential Opportunities to Minimize BiasSemantic proximity Read ↗

What Ails Drug Supply Chains? A Model for Diagnosis and Suggestions for a CureSemantic proximity Read ↗

Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct-acting antivirals.Semantic proximity Read ↗

Treatment of HCV in the Department of Corrections in the Era of Oral Medications.Semantic proximity Read ↗

Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trialSemantic proximity Read ↗

Supply Chain Vulnerabilities in First-Line Treatments for Sexually Transmitted Infections: Implications for U.S. Public Health PreparednessSemantic proximity Read ↗

Patients' Attitudes towards Switching to National Volume-Based Procurement (NVBP) Drugs -A Qualitative Investigation in Wuhan, ChinaSemantic proximity Read ↗

HCV screening, linkage to care, and treatment patterns at different sites across one academic medical centerSemantic proximity Read ↗

Barriers of linkage to HCV viremia testing among people who inject drugs in GeorgiaSemantic proximity Read ↗

The HIV Care Cascade Measured Over Time and by Age, Sex, and Race in a Large National Integrated Care SystemSemantic proximity Read ↗

Closing the Loop: An Integrative Framework for Managing Unwanted Pharmaceuticals During COVID-19 and BeyondSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.